• 3 Types of Cryptocurrencies That Can Diversify a Tech-Heavy Portfolio
  • Cathie Wood Invest Dumps Over $10 Million Of Palantir Stock Amid Talk Of 'Cramer Curse' — Buys This Hot AI Stock Instead
  • Cardano Stalls at Breakout Point: Holder Shifts Now Weaken The 50% Rally Hope
  • GQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETF
  • SOXX Delivered Larger Gains Than XLK, but With Greater Risk and Volatility
  • President Sells 25,000 EverCommerce Shares for $250,000
  • 'There Could Be A Whole Other Life He's Living' 'The Ramsey Show' Host Says After Wife Finds $209K Debt Behind Her Back
  • I'm thinking of forgoing health insurance in 2026 because I can barely afford it. What are my options?
  • Why Ubiquiti Rallied 67% in 2025
  • Here’s What Analysts Think About Biogen Inc. (BIIB)
  • AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research
  • Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why
  • Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences
  • Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why
  • Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights
  • Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32
  • Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14
  • Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance
  • Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases
  • Jim Cramer on AeroVironment: “That’s a Terrific Company”
  • Jim Cramer on Procter & Gamble: “It Has the Opportunity to Shake Things Up”
  • Jim Cramer on Microsoft: “Stock’s Been Punished By the Fact That Management Wants to Spend a Fortune on AI”
  • Jim Cramer Discusses CrowdStrike After Jensen Huang’s Endorsement
  • Jim Cramer on JPMorgan: “You Wait for the Reaction to Jamie’s Cautious Commentary to Give You a Better Entry Point”
  • Jim Cramer on Wingstop: “I Can’t Pound the Table When We Still Have Too High Food Inflation”
  • Jim Cramer on Rambus: “It’s Not That Expensive Versus Growth”
  • Jim Cramer on Nebius: “The Opportunities Are Better Elsewhere”
  • Jim Cramer on Palo Alto: “I Think It Is a Buy”
  • Jim Cramer Says He “Wouldn’t Mind a Speculative Position Only on Roblox”
  • Jim Cramer Medline: “It’s a Terrific Company”
  • Jim Cramer Says “Fermi’s More of a Business Plan Than a Business”
  • Jim Cramer Discusses CoreWeave’s IPO Surge and Pullback
  • Jim Cramer on Circle Internet: “On Paper, This One’s a Standout”
  • Jim Cramer on Celsius Holdings: “The Company’s Doing Quite Well”
  • Is BellRing Brands (BRBR) One of the Oversold Stocks to Buy Now?
  • Bernstein Gives Coinbase (COIN) an Outperform Rating Amid Tokenization Supercycle Outlook
  • Raymond James Upgrades WaterBridge Infrastructure (WBI) to Strong Buy Following Midstream Sector Rating Adjustments
  • Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement
  • BMO Capital Maintains Positive Long-Term Outlook for Vital Farms (VITL) Despite Temporary 2025 Revision
  • Roth Capital Notes Unexpected Cancellation of ReNew Energy (RNW) Take-Private Deal Following Masdar Withdrawal
  • BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60
  • Trump’s call for 10% credit-card cap aims at banks’ crown jewels
  • Daily Spotlight: Unemployment Rate Drops to 4.4%